FAS and type 2 diabetes mellitus: On the other hand, the administration of monounsaturated fatty acid FA (16:1) to KKAy mice (a T2DM model with low insulin sensitivity) can reduce fasting glycemia and insulin resistance in parallel with reduced relative mRNA expression of FAS (Yang et al., 2011).